Vancomycin injection recalled for lack of sterility assurance
Vancomycin 1.5g in 0.9% saline solution being recalled due to lack of assurance of sterility. Product distributed in Missouri with lot numbers AC-016629 and AC-016646.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an injectable medication where lack of sterility assurance creates potential for serious infection. As a risk-of-harm product with no reported injuries in the source material, it meets the criteria for High (3) severity.
Plain-English summary
Apollo Care, LLC is recalling VANComycin 1.5g added to 500 mL of 0.9% Sodium Chloride Injection (NDC 71170-185-50). The recall affects 2040 bags distributed in Missouri, with lot numbers AC-016629 (expiration 05/13/2023) and AC-016646 (expiration 06/24/2023).
The product is being recalled due to lack of assurance of sterility. Injectable medications must be sterile to prevent bacterial and other contamination that could cause serious infection in patients receiving treatment.
Healthcare providers and facilities that received affected product should discontinue use immediately and contact Apollo Care, LLC or their pharmacy supplier for instructions on returning or destroying the product. Patients who may have received this medication should speak with their healthcare provider if they have concerns about their treatment.
The recalled product
- Product
- VANComycin 1.5g added to 500 mL of 0.9% Sodium Chloride Injection, Rx only, Apollo Care, LLC, 3801 Mojave Ct., Suite 101, Columbia, MO 65202. NDC 71170-185-50
- Manufacturer
- Apollo Care, LLC
- Category
- Drug — Injectable / Infusion
- Hazard
- sterility-failure
- contamination-risk
- infection-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot#: AC-016629
- Exp. Date 05/13/2023
- AC-016646
- Exp. Date 06/24/2023
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27